Literature DB >> 20657550

S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response.

Keng Po Lai1, Wai Fook Leong, Jenny Fung Ling Chau, Deyong Jia, Li Zeng, Huijuan Liu, Lin He, Aijun Hao, Hongbing Zhang, David Meek, Chakradhar Velagapudi, Samy L Habib, Baojie Li.   

Abstract

p53 mediates DNA damage-induced cell-cycle arrest, apoptosis, or senescence, and it is controlled by Mdm2, which mainly ubiquitinates p53 in the nucleus and promotes p53 nuclear export and degradation. By searching for the kinases responsible for Mdm2 S163 phosphorylation under genotoxic stress, we identified S6K1 as a multifaceted regulator of Mdm2. DNA damage activates mTOR-S6K1 through p38alpha MAPK. The activated S6K1 forms a tighter complex with Mdm2, inhibits Mdm2-mediated p53 ubiquitination, and promotes p53 induction, in addition to phosphorylating Mdm2 on S163. Deactivation of mTOR-S6K1 signalling leads to Mdm2 nuclear translocation, which is facilitated by S163 phosphorylation, a reduction in p53 induction, and an alteration in p53-dependent cell death. These findings thus establish mTOR-S6K1 as a novel regulator of p53 in DNA damage response and likely in tumorigenesis. S6K1-Mdm2 interaction presents a route for cells to incorporate the metabolic/energy cues into DNA damage response and links the aging-controlling Mdm2-p53 and mTOR-S6K pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20657550      PMCID: PMC2944047          DOI: 10.1038/emboj.2010.166

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

Review 1.  Posttranslational modification of MDM2.

Authors:  David W Meek; Uwe Knippschild
Journal:  Mol Cancer Res       Date:  2003-12       Impact factor: 5.852

2.  S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.

Authors:  Mario Pende; Sung Hee Um; Virginie Mieulet; Melanie Sticker; Valerie L Goss; Jurgen Mestan; Matthias Mueller; Stefano Fumagalli; Sara C Kozma; George Thomas
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  HDM2 phosphorylation by MAPKAP kinase 2.

Authors:  Hans Oliver Weber; Robert L Ludwig; Deborah Morrison; Alexey Kotlyarov; Matthias Gaestel; Karen H Vousden
Journal:  Oncogene       Date:  2005-03-17       Impact factor: 9.867

4.  The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3.

Authors:  Yong Li; Ken Inoki; Panayiotis Vacratsis; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

5.  Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.

Authors:  O Jameel Shah; Zhiyong Wang; Tony Hunter
Journal:  Curr Biol       Date:  2004-09-21       Impact factor: 10.834

6.  Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export.

Authors:  Tomomi Shinozaki; Ayumi Nota; Yoichi Taya; Koji Okamoto
Journal:  Oncogene       Date:  2003-12-04       Impact factor: 9.867

7.  Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta.

Authors:  Baojie Li; Xueying Wang; Naslin Rasheed; Yuanyu Hu; Sharon Boast; Tetsuro Ishii; Keiko Nakayama; Keiichi I Nakayama; Stephen P Goff
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

8.  Attenuation of the p53 response to DNA damage by high cell density.

Authors:  Jair Bar; Efrat Cohen-Noyman; Benjamin Geiger; Moshe Oren
Journal:  Oncogene       Date:  2004-03-18       Impact factor: 9.867

9.  Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.

Authors:  Colin Selman; Jennifer M A Tullet; Daniela Wieser; Elaine Irvine; Steven J Lingard; Agharul I Choudhury; Marc Claret; Hind Al-Qassab; Danielle Carmignac; Faruk Ramadani; Angela Woods; Iain C A Robinson; Eugene Schuster; Rachel L Batterham; Sara C Kozma; George Thomas; David Carling; Klaus Okkenhaug; Janet M Thornton; Linda Partridge; David Gems; Dominic J Withers
Journal:  Science       Date:  2009-10-02       Impact factor: 47.728

10.  The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins.

Authors:  Laura S Harrington; Greg M Findlay; Alex Gray; Tatiana Tolkacheva; Simon Wigfield; Heike Rebholz; Jill Barnett; Nick R Leslie; Susan Cheng; Peter R Shepherd; Ivan Gout; C Peter Downes; Richard F Lamb
Journal:  J Cell Biol       Date:  2004-07-12       Impact factor: 10.539

View more
  52 in total

1.  A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells.

Authors:  Lauren E Nelson; Rudy J Valentine; José M Cacicedo; Marie-Soleil Gauthier; Yasuo Ido; Neil B Ruderman
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-29       Impact factor: 4.249

Review 2.  Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.

Authors:  Mihaela Aldea; Lucian Craciun; Ciprian Tomuleasa; Ioana Berindan-Neagoe; Gabriel Kacso; Ioan Stefan Florian; Carmen Crivii
Journal:  Tumour Biol       Date:  2014-02-07

Review 3.  Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.

Authors:  Joydeep Ghosh; Reuben Kapur
Journal:  Exp Hematol       Date:  2017-03-22       Impact factor: 3.084

4.  Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients.

Authors:  Pin Dong Li; Wen Jie Zhang; Mei Ying Zhang; Lin Jing Yuan; Yin Lian Cha; Xiao Fang Ying; Gang Wu; Hui Yun Wang
Journal:  Med Oncol       Date:  2012-06-10       Impact factor: 3.064

5.  mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.

Authors:  Kaveh M Goudarzi; Monica Nistér; Mikael S Lindström
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

6.  mTORC1 and p53: clash of the gods?

Authors:  Paul Hasty; Zelton Dave Sharp; Tyler J Curiel; Judith Campisi
Journal:  Cell Cycle       Date:  2013-01-01       Impact factor: 4.534

7.  Adult-onset, short-term dietary restriction reduces cell senescence in mice.

Authors:  Chunfang Wang; Mandy Maddick; Satomi Miwa; Diana Jurk; Rafal Czapiewski; Gabriele Saretzki; Sabine A S Langie; Roger W L Godschalk; Kerry Cameron; Thomas von Zglinicki
Journal:  Aging (Albany NY)       Date:  2010-09       Impact factor: 5.682

8.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03

9.  A viral kinase mimics S6 kinase to enhance cell proliferation.

Authors:  Aadra Prashant Bhatt; Jason P Wong; Marc S Weinberg; Kurtis M Host; Louise C Giffin; Joshua Buijnink; Evert van Dijk; Yoshihiro Izumiya; Hsing-Jien Kung; Brenda R S Temple; Blossom Damania
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-24       Impact factor: 11.205

10.  A new mechanism of regulation of p21 by the mTORC1/4E-BP1 pathway predicts clinical outcome of head and neck cancer.

Authors:  Susana Llanos; Juana M García-Pedrero
Journal:  Mol Cell Oncol       Date:  2016-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.